Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy

被引:2
|
作者
Su, Jia-Yong [1 ]
Wu, Ying-Ling [1 ]
Wu, Xuan-Lin [1 ]
Liu, Zhen-Xiu [1 ]
Wang, Yi-Yang [1 ]
Li, Zhong-Hai [1 ]
Luo, Jia-Xin [1 ]
Wu, Kun-Jun [1 ]
Zhong, Jian-Hong [1 ,2 ,3 ]
机构
[1] Guangxi Med Univ Canc Hosp, Hepatobiliary Surg Dept, He Di Rd 71, Nanning 530021, Peoples R China
[2] Guangxi Med Univ, Key Lab Early Prevent & Treatment Reg High Frequen, Minist Educ, Nanning, Peoples R China
[3] Guangxi Key Lab Early Prevent & Treatment Reg High, Nanning, Peoples R China
关键词
D O I
10.1111/apt.17668
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
LINKED CONTENT This article is linked to Ogawa et al papers. To view these articles, visit and .
引用
收藏
页码:842 / 844
页数:3
相关论文
共 50 条
  • [21] Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
    Kim, Jung Hee
    Sinn, Dong Hyun
    Kim, Kyunga
    Kim, Hyeseung
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    GUT AND LIVER, 2016, 10 (06) : 939 - 947
  • [22] Reply on "Tenofovir is Associated With a Better Prognosis Than Entecavir for Hepatitis B Virus-related Hepatocellular Carcinoma"
    Chang, Kai-chun
    Su, Tung-hung
    Kao, Jia-horng
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2025, 23 (04) : 680 - 681
  • [23] Entecavir and Tenofovir More Effectively Reduce the Recurrence of Hepatitis B Virus-related Hepatocellular Carcinoma after Curative Treatment than Low-potent Antivirals
    Ahn, Hongkeun
    Lee, Jeong-Hoon
    Chang, Young
    Nam, Joon Yeul
    Cho, Hyeki
    Cho, Young Youn
    Lee, Minjong
    Yoo, Jeong-Ju
    Cho, Yuri
    Lee, Donghyeon
    Cho, Eun Ju
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, June Sung
    HEPATOLOGY, 2015, 62 : 1191A - 1192A
  • [24] Letter to the Editor: Tenofovir vs. Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection
    Yuan, Guandou
    Yao, Jianni
    Yu, Jingjing
    Xie, Xuemei
    He, Songqing
    HEPATOLOGY, 2021, 73 (03) : 1240 - 1240
  • [25] Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy
    Yang Ke
    Liang Ma
    Xue-Mei You
    Sheng-Xin Huang
    Yong-Rong Liang
    Bang-De Xiang
    Le-Qun Li
    Cancer Biology & Medicine, 2013, (03) : 158 - 164
  • [26] Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy
    Yang Ke
    Liang Ma
    Xue-Mei You
    Sheng-Xin Huang
    Yong-Rong Liang
    Bang-De Xiang
    Le-Qun Li
    Cancer Biology & Medicine, 2013, 10 (03) : 158 - 164
  • [27] Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a reconstructed individual patient data meta-analysis
    Peng, Jian-Xin
    Wang, Ling-Zhi
    Wang, Qiu-Ting
    Li, Hui-Long
    Lin, Li-Jun
    He, Jun-Ming
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [28] Nomograms in Hepatectomy Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
    Jong Man Kim
    Choon Hyuck David Kwon
    Jae-Won Joh
    Heejin Yoo
    Kyunga Kim
    Dong Hyun Sinn
    Gyu-Seong Choi
    Joon Hyeok Lee
    Journal of Gastrointestinal Surgery, 2019, 23 : 1559 - 1567
  • [29] Nomograms in Hepatectomy Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
    Kim, Jong Man
    Kwon, Choon Hyuck David
    Joh, Jae-Won
    Yoo, Heejin
    Kim, Kyunga
    Sinn, Dong Hyun
    Choi, Gyu-Seong
    Lee, Joon Hyeok
    JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (08) : 1559 - 1567
  • [30] Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma
    Shin, Hye Sun
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Baatarkhuu, Oidov
    Ahn, Sang Hoon
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (09) : 1528 - 1534